We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · July 15, 2021

Early Antiviral Therapy in Liver/Kidney Transplant Recipients of HCV-Viremic Donors

Hepatology (Baltimore, Md.)


Additional Info

Hepatology (Baltimore, Md.)
Prospective Multicenter Study of Early Antiviral Therapy in Liver and Kidney Transplant Recipients of HCV-Viremic Donors
Hepatology 2021 Jun 01;73(6)2110-2123, NA Terrault, J Burton, M Ghobrial, E Verna, J Bayer, C Klein, D Victor, S Mohan, J Trotter, J Dodge, CU Niemann, RA Rubin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading